title: Are the serum levels of sCD40L modified by raloxifene in postmenopausal women?
authors.forename: Pilar J
authors.initials: PJ
authors.lastname: Oviedo
authors.forename: Carlos
authors.initials: C
authors.lastname: Hermenegildo
authors.forename: Susana
authors.initials: S
authors.lastname: Novella
authors.forename: Juan J
authors.initials: JJ
authors.lastname: Tarín
authors.forename: Antonio
authors.initials: A
authors.lastname: Cano
mesh_terms: D023201:CD40 Ligand / Q000097:blood*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D020849:Raloxifene Hydrochloride / Q000494:pharmacology* / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D020845:Selective Estrogen Receptor Modulators; D023201:CD40 Ligand; D020849:Raloxifene Hydrochloride